Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Agonist antibody discovery: Experimental, computational, and rational engineering approaches. | Drug Discov Today | 2022 | 34571277 | PubTator, text mining | PubMed |
| Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM. | J Nucl Med | 2022 | 34353869 | PubTator, text mining | PubMed |
| CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies. | Cell Mol Immunol | 2022 | 34282297 | PubTator, text mining | PubMed |
| Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis. | Rheumatology (Oxford) | 2022 | 34175943 | PubTator, text mining | PubMed |
| Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease? | Clin Rev Allergy Immunol | 2022 | 34115263 | PubTator, text mining | PubMed |
| An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways. | Anal Bioanal Chem | 2022 | 34021368 | PubTator, text mining | PubMed |
| Cellular immune responses in the pathophysiology of preeclampsia. | J Leukoc Biol | 2022 | 33847419 | PubTator, text mining | PubMed |
| Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes. | Haematologica | 2022 | 33567812 | PubTator, text mining | PubMed |
| COVID-19: inflammatory responses, structure-based drug design and potential therapeutics. | Mol Divers | 2022 | 33400086 | PubTator, text mining | PubMed |
| Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus. | Rheumatol Immunol Res | 2021 | 36465073 | PubTator, text mining | PubMed |
| Missense variant in interleukin-6 signal transducer identified as susceptibility locus for rheumatoid arthritis in Chinese patients. | Arch Rheumatol | 2021 | 35382366 | PubTator, text mining | PubMed |
| The Role of IgG4 in Autoimmunity and Rheumatic Diseases. | Front Immunol | 2021 | 35145508 | PubTator, text mining | PubMed |
| A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis via Network Pharmacology and Molecular Docking. | Front Cell Dev Biol | 2021 | 35127697 | PubTator, text mining | PubMed |
| Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity. | Nat Cancer | 2021 | 35121890 | PubTator, text mining | PubMed |
| Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma. | Transl Cancer Res | 2021 | 35116502 | PubTator, text mining | PubMed |
| Identification of CDK1 as a candidate marker in cutaneous squamous cell carcinoma by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116276 | PubTator, text mining | PubMed |
| Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges. | Front Immunol | 2021 | 35116040 | PubTator, text mining | PubMed |
| Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma. | Front Genet | 2021 | 35111196 | PubTator, text mining | PubMed |
| The Role of miRNAs as New Molecular Biomarkers for Dating the Age of Wound Production: A Systematic Review. | Front Med (Lausanne) | 2021 | 35096893 | PubTator, text mining | PubMed |
| Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases. | Front Oncol | 2021 | 35096583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=55